Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Caleb Alexander

Showing results (121-130 of 414) with videos related to

Pageof 42
Sort By:
Plos One|March 5, 2015
National trends in the ambulatory treatment of hypertension in the United States, 1997-2012Meijia Zhou, Matthew Daubresse, Randall S Stafford, et al.
RMD Open|April 17, 2021
Comparative effectiveness of biologics and targeted therapies for psoriatic arthritisHanzhe Zhang, Jiajun Wen, G Caleb Alexander, et al.
Journal of General Internal Medicine|July 20, 2011
National trends in ambulatory asthma treatment, 1997-2009Ashley Higashi, Shu Zhu, Randall S Stafford, et al.
Social Science & Medicine (1982)|August 13, 2005
A conceptually based approach to understanding chronically ill patients' responses to medication cost pressuresJohn D Piette, Michele Heisler, Robert Horne, et al.
Plos One|March 8, 2013
Promotion of prescription drugs to consumers and providers, 2001-2010Rachel Kornfield, Julie Donohue, Ernst R Berndt, et al.
Addiction (Abingdon, England)|January 21, 2017
Non-buprenorphine opioid utilization among patients using buprenorphineMatthew Daubresse, Brendan Saloner, Harold A Pollack, et al.
Addiction (Abingdon, England)|September 30, 2021
Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov modelG Caleb Alexander, Jeromie Ballreich, Omar Mansour, et al.
Annals of Internal Medicine|March 18, 2003
Support for physician deception of insurance companies among a sample of Philadelphia residentsG Caleb Alexander, Rachel M Werner, Angela Fagerlin, et al.
Plos One|February 14, 2019
Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort studyYunwen Xu, Scott J Pilla, G Caleb Alexander, et al.
Clinical Therapeutics|December 24, 2017
Exposure- and Dose-response Analyses in Dose Selection and Labeling of FDA-approved BiologicsKen Ogasawara, Christopher D Breder, Dora H Lin, et al.
Pageof 42

Showing results (121-130 of 414) with videos related to

Sort By:
Pageof 42
Plos One|March 5, 2015
National trends in the ambulatory treatment of hypertension in the United States, 1997-2012Meijia Zhou, Matthew Daubresse, Randall S Stafford, et al.
RMD Open|April 17, 2021
Comparative effectiveness of biologics and targeted therapies for psoriatic arthritisHanzhe Zhang, Jiajun Wen, G Caleb Alexander, et al.
Journal of General Internal Medicine|July 20, 2011
National trends in ambulatory asthma treatment, 1997-2009Ashley Higashi, Shu Zhu, Randall S Stafford, et al.
Social Science & Medicine (1982)|August 13, 2005
A conceptually based approach to understanding chronically ill patients' responses to medication cost pressuresJohn D Piette, Michele Heisler, Robert Horne, et al.
Plos One|March 8, 2013
Promotion of prescription drugs to consumers and providers, 2001-2010Rachel Kornfield, Julie Donohue, Ernst R Berndt, et al.
Addiction (Abingdon, England)|January 21, 2017
Non-buprenorphine opioid utilization among patients using buprenorphineMatthew Daubresse, Brendan Saloner, Harold A Pollack, et al.
Addiction (Abingdon, England)|September 30, 2021
Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov modelG Caleb Alexander, Jeromie Ballreich, Omar Mansour, et al.
Annals of Internal Medicine|March 18, 2003
Support for physician deception of insurance companies among a sample of Philadelphia residentsG Caleb Alexander, Rachel M Werner, Angela Fagerlin, et al.
Plos One|February 14, 2019
Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort studyYunwen Xu, Scott J Pilla, G Caleb Alexander, et al.
Clinical Therapeutics|December 24, 2017
Exposure- and Dose-response Analyses in Dose Selection and Labeling of FDA-approved BiologicsKen Ogasawara, Christopher D Breder, Dora H Lin, et al.
Pageof 42